Andere Kunden interessierten sich auch für
![Formulation Strategies for dissolution enhancement of insoluble drugs]( "Formulation Strategies for dissolution enhancement of insoluble drugs")
Formulation Strategies for dissolution enhancement of insoluble drugs44,99 €![Lipid lowering drugs in induced non-alcoholic steatohepatitis in rats]( "Lipid lowering drugs in induced non-alcoholic steatohepatitis in rats")
Lipid lowering drugs in induced non-alcoholic steatohepatitis in rats36,99 €![Serum Lipid Profile]( "Serum Lipid Profile")
Serum Lipid Profile32,99 €![Solid Lipid Nanoparticles: In-vitro/In-vivo Characterization]( "Solid Lipid Nanoparticles: In-vitro/In-vivo Characterization")
Solid Lipid Nanoparticles: In-vitro/In-vivo Characterization32,99 €![Solid Dispersion of Dronedarone HCl for Better Dissolution Profile]( "Solid Dispersion of Dronedarone HCl for Better Dissolution Profile")
Solid Dispersion of Dronedarone HCl for Better Dissolution Profile26,99 €![Serum Nitric Oxide and Lipid profile in Type 2 Diabetes Mellitus]( "Serum Nitric Oxide and Lipid profile in Type 2 Diabetes Mellitus")
Serum Nitric Oxide and Lipid profile in Type 2 Diabetes Mellitus46,99 €![LIPID PEROXIDATION, ANTIOXIDANT STATUS AND LIPID PROFILE IN PREECLAMPSIA]( "LIPID PEROXIDATION, ANTIOXIDANT STATUS AND LIPID PROFILE IN PREECLAMPSIA")
LIPID PEROXIDATION, ANTIOXIDANT STATUS AND LIPID PROFILE IN PREECLAMPSIA32,99 €
The rate and extent of dissolution of the active ingredient from any solid dosage form determines the rate and extent of absorption of the drug. Potential bioavailability problems are prevalent with extremely hydrophobic drugs due to erratic or incomplete absorption from gastro intestinal tract. Clinically, HMG Coenzyme reductase inhibitors are the most frequently prescribed drugs for cholesterol reduction. Simvastatin, potent inhibitor of 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase which catalyzes the conversion of 3-hydroxy-3-methyl-glutaryl-coenzyme A to mevalonate, which is an early and rate-limiting step in the biosynthesis of cholesterol. Simvastatin is a poorly absorbed from the gastrointestinal tract because of it solubility. According to the Biopharmaceutical Classification System it is under class II (Low Solubility and High Permeability) thus, dissolution is a rate-limiting step for its absorption. In the light of above fact, the present study has been undertaken with objectives of improve the dissolution of simvastatin by preparing inclusion complex with cyclodextrin derivatives and solid dispersion with hydrophilic polymers.